Page 472 - மக்கள் தொகை கணக்கெடுப்பு எடுப்பவர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad. In his virtual address at the 25th meeting of the Group of Ministers, the Health Minister said, “180 districts have showed no fresh cases in the last seven days, 18 districts in 14 days, 54 districts in 21 days and 32 districts were bereft of any fresh cases in the last 28 days.” He said that across the country, the number of patients in ICU beds is 4,88,861 while 1,70,841 patients were on ventilators and 9,02,291 patients were on oxygen support.

Uttar pradeshAndhra pradeshRavider pal singhGroup of ministersUnion health ministryEuropean commissionHealth ministryDefence researchSupreme courtMaldives policeInstitute of nuclear medicineDevelopment organisationDrugs controller generalNuclear medicineAllied sciencesHealth minister